OTCMKTS:SIGY

Sigyn Therapeutics (SIGY) Stock Forecast, Price & News

$0.09

0.00 (0.00%)

(As of 06/7/2023 ET)

Compare

Today's Range: $0.09
▼
$0.09
50-Day Range: $0.07
▼
$0.18
52-Week Range: $0.07
▼
$0.48

Volume: N/A
Average Volume: 5,341 shs
Market Capitalization: $3.48 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Earnings Financials Headlines SEC Filings Short Interest

About Sigyn Therapeutics (OTCMKTS:SIGY) Stock

Sigyn Therapeutics, Inc. is a development-stage company, which focuses on creating therapeutic solutions that address unmet needs in global health. Its product, Sigyn Therapy, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders that are not addressed with approved drug therapies. The company was founded by James A. Joyce and Craig P. Roberts on October 19, 2019 and is headquartered in San Diego, CA.

Receive SIGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sigyn Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SIGY Stock News Headlines

June 3, 2023 | americanbankingnews.com

Reviewing Bioventus (NYSE:BVS) and Sigyn Therapeutics (OTCMKTS:SIGY)

May 22, 2023 | fool.com

Beam Therapeutics (NASDAQ: BEAM)

June 8, 2023 | Behind the Markets (Ad)

The single greatest medical breakthrough of all time?

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

May 17, 2023 | finance.yahoo.com

Sigyn Therapeutics Discloses “DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES” Patent Submission and Related ImmunePrep™ Trademark Application

May 16, 2023 | finanznachrichten.de

Sigyn Therapeutics, Inc.: Sigyn Therapeutics Reports First Quarter 2023 Financial Results

May 16, 2023 | finance.yahoo.com

Sigyn Therapeutics Reports First Quarter 2023 Financial Results

April 15, 2023 | americanbankingnews.com

Sigyn Therapeutics, Inc. (OTCMKTS:SIGY) Short Interest Update

April 11, 2023 | finance.yahoo.com

Sigyn Therapeutics™ Announces Appointment of Annette Marleau, Ph.D. as Chief Scientific Officer

June 8, 2023 | Behind the Markets (Ad)

The single greatest medical breakthrough of all time?

March 31, 2023 | finance.yahoo.com

Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K

March 21, 2023 | forbes.com

Chinook Therapeutics

February 25, 2023 | seekingalpha.com

Jounce Therapeutics downgraded to market perform at Raymond James on company restructuring

See More Headlines

SIGY Price History

30 days | 90 days | 365 days | Advanced Chart

SIGY Company Calendar

Last Earnings: 5/16/2023
Today: 6/07/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:SIGY
CUSIP: N/A
CIK: 1642159
Web: www.sigyntherapeutics.com
Phone: (619) 353-0800
Fax: N/A
Employees: 5
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-2,930,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -820.79%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.15
Quick Ratio: 0.13

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.05) per share
Price / Book: -1.82

Miscellaneous

Outstanding Shares: 38,264,000
Free Float: 8,242,000
Market Cap: $3.48 million
Optionable: Not Optionable
Beta: -1.44

Key Executives

James A. Joyce
Chairman & Chief Executive Officer

Charlene R. Owen
Director-Operations

Jeremy Lee Ferrell
Chief Financial Officer

Craig P. Roberts
Director & Chief Technology Officer

Eric Lynam
Director-Clinical Affairs

Key Competitors

View All Competitors

SIGY Stock - Frequently Asked Questions

How have SIGY shares performed in 2023?: Sigyn Therapeutics' stock was trading at $0.17 at the start of the year. Since then, SIGY stock has decreased by 46.5% and is now trading at $0.0910.
View the best growth stocks for 2023 here.
How were Sigyn Therapeutics' earnings last quarter?: Sigyn Therapeutics, Inc. (OTCMKTS:SIGY) posted its quarterly earnings results on Tuesday, May, 16th. The company reported ($0.03) EPS for the quarter.
What is Sigyn Therapeutics' stock symbol?: Sigyn Therapeutics trades on the OTCMKTS under the ticker symbol "SIGY."

How do I buy shares of Sigyn Therapeutics?: Shares of SIGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Sigyn Therapeutics' stock price today?: One share of SIGY stock can currently be purchased for approximately $0.09.
How much money does Sigyn Therapeutics make?: Sigyn Therapeutics (OTCMKTS:SIGY) has a market capitalization of $3.48 million.
How can I contact Sigyn Therapeutics?: Sigyn Therapeutics' mailing address is 2468 Historic Decatur Road Ste. 140, San Diego CA, 92106. The official website for the company is www.sigyntherapeutics.com. The company can be reached via phone at (619) 353-0800 or via email at stephen@sigyntherapeutics.com.

This page (OTCMKTS:SIGY) was last updated on 6/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial